About
Monoclonal Antibodies
Areas of Focus
Categories
BiosimilarsAntibodyPoland
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
852
By Phase
PHASE3: 3
By Status
COMPLETED: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Today
Hover over trial bars to see details
Recent Trials
NCT04680962Lead Sponsor
MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis
PHASE3Withdrawn
Started: Aug 3, 2023 · Completed: Aug 3, 2023
NCT02617485Lead Sponsor
MabionCD20 Compared to MabThera in Lymphoma Patients
PHASE3Completed
143 participants
Started: Dec 31, 2015 · Completed: Jan 31, 2018
NCT02468791Lead Sponsor
MabionCD20® Compared to MabThera® in Patients With Rheumatoid Arthritis
PHASE3Completed
709 participants
Started: May 31, 2013 · Completed: Oct 31, 2017
Locations (1)
Headquarters
Konstantynów, Poland
Map
Loading map...